DIHEXA Caps (10mg)
DIHEXA (N-Hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic peptide-derived compound studied in neuroscience and synaptic signaling research. This capsule format delivers DIHEXA in a stabilized oral dosage form for laboratory research use.
Researchers study DIHEXA primarily for its interaction with hepatocyte growth factor (HGF) and c-Met receptor signaling pathways, which are associated with synaptic connectivity and neural communication.
GENIQ supplies DIHEXA Caps strictly for laboratory research only—not for human or animal use.
$249.99
-
Official retailer
-
Quality guaranteed
-
Free delivery from $99
-
Free returns is available
What Is DIHEXA Caps?
DIHEXA (N-Hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic peptide-derived compound studied in neuroscience and synaptic signaling research. This capsule format delivers DIHEXA in a stabilized oral dosage form for laboratory research use. Researchers study DIHEXA primarily for its interaction with hepatocyte growth factor (HGF) and c-Met receptor signaling pathways, which are associated with synaptic connectivity and neural communication. GENIQ supplies DIHEXA Caps strictly for laboratory research only—not for human or animal use.
Peptide Overview
DIHEXA is frequently studied in research focused on neurobiology, synaptic plasticity, and cellular signaling within the central nervous system. In controlled laboratory environments, researchers examine how DIHEXA Caps may promote changes in:
| Synaptogenesis-related signaling pathways |
| Neuronal growth and connectivity markers |
| Hepatocyte growth factor (HGF) receptor activity |
| Neuroplasticity-associated gene expression |
| Memory and learning molecular pathways |
| Neural cell communication models |
| Brain-derived signaling and structural protein activity |
All findings remain limited to preclinical and in-vitro experimental environments.
History of DIHEXA Caps
DIHEXA was developed during research aimed at modifying angiotensin IV analogs to create molecules capable of interacting with neural growth signaling pathways. Scientists discovered that DIHEXA binds to hepatocyte growth factor (HGF), a protein involved in neuronal development and synaptic connectivity. Because of this interaction, DIHEXA became a compound of interest in studies involving:
| Synaptic formation and plasticity |
| Neurodegenerative disease models |
| Learning and memory mechanisms |
| Neural growth signaling pathways |
| HGF/c-Met receptor system interactions |
| Brain cellular communication models |
Peptide Structure
Chemical Name: N-Hexanoic-Tyr-Ile-(6) aminohexanoic amide Derived From: Angiotensin IV analog Form Supplied: Oral capsule, 10mg per capsule (60 capsules per bottle)
Certificates of Analysis
Every batch of GENIQ DIHEXA Caps is verified by third-party laboratory testing confirming identity, purity, and capsule content accuracy. Certificates of Analysis (COA) are available upon request for research verification.
Research Findings
Research involving DIHEXA commonly focuses on:
| Synaptic formation signaling: Studies evaluate molecular pathways associated with new synapse development. |
| HGF/c-Met receptor activity: Researchers investigate how DIHEXA interacts with hepatocyte growth factor signaling systems. |
| Neuroplasticity markers: Laboratory models track biochemical changes related to neuronal connectivity and structural proteins. |
| Memory and learning pathways: Experimental studies analyze cellular processes associated with cognitive signaling networks. |
| Gene-expression modulation: Investigations explore transcriptional activity related to neurodevelopmental pathways. |
These findings reflect laboratory experiments only and do not indicate clinical outcomes.
References
FAQ
What type of research is DIHEXA Caps used for?
DIHEXA Caps is commonly used in studies involving synaptic plasticity, neuronal signaling, growth-factor pathways, and neurobiology research.
Does GENIQ provide a Certificate of Analysis?
Yes. Every GENIQ compound includes a COA verifying identity and purity.
Is DIHEXA approved for human or veterinary use?
No. DIHEXA is not FDA-approved and is intended strictly for laboratory research, not for human or animal administration.
Does GENIQ provide dosing or preparation instructions?
No. GENIQ does not provide dosing, administration, or preparation instructions, as our compounds are supplied strictly for laboratory research.
Who should handle this compound?
DIHEXA Caps should only be handled by qualified researchers and laboratory professionals trained in proper handling procedures.
Research Use Only
All GENIQ compounds are intended strictly for laboratory research.
Not for human or animal consumption, medical use, or therapeutic application.
Nothing in this document should be interpreted as medical advice or as approval for use outside controlled scientific environments.
DIHEXA (N-Hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic peptide-derived compound studied in neuroscience and synaptic signaling research. This capsule format delivers DIHEXA in a stabilized oral dosage form for laboratory research use.
Researchers study DIHEXA primarily for its interaction with hepatocyte growth factor (HGF) and c-Met receptor signaling pathways, which are associated with synaptic connectivity and neural communication.
GENIQ supplies DIHEXA Caps strictly for laboratory research only—not for human or animal use.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.